| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Oravel Stays Limited |
|
Particular |
31-03-2025 |
31-03-2024 |
|
Non- Current assets |
702.50 |
522.95 |
|
Property, Plant and Equipment |
312.16 |
11.09 |
|
Capital work-in-progress |
26,252.38 |
1,794.58 |
|
Goodwill |
56,246.94 |
27,704.83 |
|
Other intangible assets |
49,273.74 |
14,376.31 |
|
Intangible assets under development |
1.09 |
1.37 |
|
Investment in joint ventures |
2,498.84 |
2,958.13 |
|
Investments |
17.89 |
14.09 |
|
Other financial assets |
1,539.52 |
746.61 |
|
Non-current tax assets (net) |
1,084.70 |
1,030.36 |
|
Other non-current assets |
1,126.65 |
714.19 |
|
Deferred tax assets (net) |
6,633.85 |
342.57 |
|
Current assets |
||
|
Inventories |
2,808.14 |
1,581.17 |
|
Trade receivables |
4,877.84 |
2,029.54 |
|
Cash and cash equivalents |
6,843.96 |
4,058.47 |
|
Bank balances other than above |
285.67 |
3,039.60 |
|
Other financial assets |
2,589.94 |
1,516.38 |
|
Other current assets |
3,857.41 |
1,992.49 |
|
Total Assets |
166,953.22 |
64,434.73 |
|
Equity |
||
|
Equity Share Capital |
6,787.35 |
1,349.87 |
|
Other Equity |
40,894.30 |
17,258.27 |
|
Non-controlling interests |
( 9,815.43) |
(9,600.82) |
|
Non-current liabilities |
||
|
Borrowings |
69,887.84 |
35,567.90 |
|
Lease liabilities |
21,290.94 |
1,625.58 |
|
Other financial liabilities |
1,548.06 |
143.47 |
|
Provisions |
113.65 |
106.56 |
|
Deferred tax liabilities |
9,316.42 |
2,767.68 |
|
Other non-current liabilities |
1,060.00 |
34.65 |
|
Current liabilities |
||
|
Borrowings |
1,552.67 |
461.82 |
|
Lease liabilities |
5,715.84 |
785.97 |
|
Total outstanding dues of micro enterprises and small enterprises |
65.33 |
22.61 |
|
Total outstanding dues other than above |
12,336.68 |
9,610.23 |
|
Other financial liabilities |
3,246.88 |
1,349.79 |
|
Provision |
69.90 |
67.01 |
|
Current tax liabilities (net) |
423.88 |
311.29 |
|
Other current liabilities |
2,458.91 |
2,572.85 |
|
Total equity and liabilities |
166,953.22 |
64,434.73 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Revenue from operations |
62,528.30 |
53,887.89 |
|
Other Income |
730.58 |
1,527.96 |
|
Total income |
63,258.88 |
55,415.85 |
|
Expenses |
|
|
|
Operating expenses |
31,295.47 |
28,854.41 |
|
Employee benefit expense |
6,160.87 |
7,443.82 |
|
Finance cost |
9,591.55 |
8,438.18 |
|
Depreciation and
amortization expense |
4,835.87 |
2,003.46 |
|
Other expenses |
14,711.66 |
10,517.95 |
|
Total expenses |
66,595.42 |
57,257.82 |
|
Profit/(loss) before share of profit in joint ventures, exceptional items and tax |
(3,336.54) |
(1,841.97) |
|
Share of profit after tax in joint ventures (net) |
113.52 |
101.40 |
|
Profit/(loss)
before exceptional items and tax |
(3,223.02) |
(1,740.57) |
|
Exceptional items |
1,670.15 |
(4,098.77) |
|
Profit/(loss) Before Tax |
(4,893.17) |
2,358.20 |
|
Current tax |
334.19 |
575.00 |
|
Deferred tax |
(7,675.58) |
(512.59) |
|
Income
tax (income)/expense |
(7,341.39) |
62.41 |
|
Profit/(loss) for the year |
2,448.22 |
2,295.79 |
|
Other comprehensive income/ (loss) not to be reclassified to profit or loss in subsequent periods |
|
|
|
Net (loss)/ gain on equity instruments through Other Comprehensive Income |
- |
(174.12) |
|
Re-measurement gain on defined benefit plans |
1.41 |
(19.95) |
|
Net other comprehensive income/ (loss) not to be reclassified to profit or loss
in subsequent periods |
1.41 |
(194.07) |
|
Other comprehensive income/(loss) to be reclassified to profit or loss in
subsequent periods |
||
|
Exchange differences on translation of financial statements of foreign operations (net) |
801.61 |
523.39 |
|
Exchange difference on net investment in foreign operation (net) |
(533.56) |
(1,213.30) |
|
Net other comprehensive income/ (loss) to be reclassified to profit or loss in
subsequent periods |
268.05 |
(689.91) |
|
Total other comprehensive income/(loss), net of tax |
269.46 |
(883.98) |
|
Total comprehensive income/(loss) for the year, net of tax |
2,717.68 |
1,411.81 |
|
Earnings per equity share |
|
|
|
Basic |
0.38 |
0.36 |
|
Diluted |
0.38 |
0.33 |
|
Particular |
31-03-2025 |
31-03-2024 |
|
Cash Flow From Operating Activities |
|
|
|
Profit/(loss) for the year |
(4,893.17) |
2,358.20 |
|
Adjustments for: |
|
|
|
Depreciation and amortisation expense |
4,835.87 |
2,003.46 |
|
(Profit)/ loss on sale of property, plant and equipment (net) |
(12.74) |
(18.76) |
|
Gain on lease modifications/termination of lease contracts (net) |
(19.76) |
- |
|
Allowance/(reversal) for expected credit loss |
771.14 |
184.61 |
|
Fair value loss/ (gain) on financial instruments at fair value through profit or loss |
(29.85) |
(10.02) |
|
Interest income on security deposits |
(55.19) |
(7.69) |
|
Profit on sale of current investments |
(196.71) |
(50.04) |
|
Interest income |
(242.01) |
(727.24) |
|
Employee stock option compensation |
323.11 |
1,276.50 |
|
Interest expense |
9,405.84 |
8,364.97 |
|
Share of profit in joint venture |
(113.52) |
(101.40) |
|
Provision/liabilities no longer required written
back |
(35.49) |
(181.85) |
|
Interest on lease receivable |
(6.00) |
(18.37) |
|
Exchange difference (net) |
(104.17) |
(389.92) |
|
Exception items |
1,109.51 |
(4,533.07) |
|
Movements in working capital : |
|
|
|
Increase/(decrease) in trade payables |
(2,820.94) |
55.52 |
|
Decrease in other non-financial liabilities |
(465.64) |
(457.16) |
|
(Decrease)/increase in provisions |
9.27 |
(17.97) |
|
(Decrease)/increase in other financial
liabilities |
134.61 |
(434.16) |
|
Decrease in other financial assets |
(969.37) |
105.99 |
|
(Increase)/decrease in other non-financial assets |
(1,573.98) |
(474.75) |
|
Decrease in inventories |
|
|
|
(Increase)/decrease in trade receivables |
(1,561.11) |
(748.94) |
|
Cash flows from/ (used in) operations |
3,489.70 |
6,177.91 |
|
Taxes Paid (net of refund) |
(277.19) |
(195.66) |
|
Net Cash generating from Operating Activities |
3,212.51 |
5,982.25 |
|
Cash Flow From Investing Activities |
|
|
|
Purchase of PPE (including intangibles, capital advance, and CWIP) (net) |
(1,533.69) |
(360.25) |
|
Proceeds from sales of PPE |
23.52 |
21.50 |
|
Purchase of investments |
(43,412.97) |
(5,775.41) |
|
Proceed from sale of investments |
42,417.40 |
5,697.25 |
|
Acquisition of subsidiaries, net of cash acquired |
(41,546.50) |
(210.66) |
|
Interest received |
243.60 |
840.90 |
|
Dividend received from joint venture |
621.70 |
148.39 |
|
Redemption/(investment) in fixed deposit (having maturity more than 3 and 12 months) |
2,798.06 |
14,039.49 |
|
Foreign exchange movement in investing activities (net) |
(1,732.55) |
(152.19) |
|
Net cash flows from/(used in) investing
activities (B) |
(42,121.43) |
14,249.02 |
|
Financing Activities |
|
|
|
Proceeds from issuance of equity share capital |
5,193.34 |
1.96 |
|
Proceeds from issuance of preference share capital (net of share issue expense of INR 93.68 million (31 March 2024: Nil) |
14,561.00 |
- |
|
Interest on borrowings |
(7,570.43) |
(6,732.59) |
|
Proceeds from long term borrowings |
68,483.05 |
- |
|
Proceeds from short term borrowings |
1,090.85 |
- |
|
Repayment of long term borrowings |
(37,901.77) |
(16,608.61) |
|
Payment of principal portion of lease liabilities |
(3,205.16) |
(748.16) |
|
Interest on lease liabilities |
(1,288.95) |
(207.45) |
|
Proceeds from sale of investment in subsidiary |
1,088.51 |
- |
|
Foreign exchange movement in financing activities (net) |
1,148.00 |
162.98 |
|
Net cash flows from/(used in) financing
activities |
41,598.45 |
(24,131.87) |
|
Net (Decrease) in Cash and Cash Equivalents |
2,689.53 |
(3,900.60) |
|
Opening balance of cash and cash equivalents |
4,082.19 |
7,964.88 |
|
Effect of exchange rate on cash and cash equivalents |
85.49 |
17.91 |
|
Closing
balance of cash and cash equivalents |
6,857.21 |
4,082.19 |
Summary of the Cash
Flow Statement for the years 2025 and 2024
Operating Activities
In FY 2025, the company reported a loss of 4,893.17 million compared to a profit of 2,358.20 million in FY 2024. Despite the loss, operating cash flow
improved through non-cash adjustments such as depreciation of 4,835.87 million (up from 2,003.46 million) and high interest
expenses of 9,405.84 million.
Provisions for expected credit loss also rose to 771.14 million. On the other hand, income from sale of investments
(196.71 million) and interest income
(242.01 million) reduced inflows.
Working capital movements were negative, with trade payables falling by 2,820.94 million and trade receivables
increasing by 1,561.11 million. As a
result, cash generated from operations was 3,489.70
million in FY 2025, lower than 6,177.91
million in FY 2024. After tax payments, net operating cash inflow stood at 3,212.51 million, compared to 5,982.25 million a year earlier.
Investing Activities
The company had heavy cash outflows in FY 2025. Purchases of investments
stood at 43,412.97 million, while
proceeds from sale of investments were 42,417.40
million. A major outflow came from acquisition of subsidiaries worth 41,546.50 million. Other movements
included purchase of property, plant, and equipment worth 1,533.69 million, redemption of fixed deposits of 2,798.06 million, and dividend income
from a joint venture of 621.70 million.
Foreign exchange movements also reduced cash by 1,732.55 million. Overall, net investing cash flow was an outflow
of 42,121.43 million in FY 2025,
compared to an inflow of 14,249.02
million in FY 2024.
Financing Activities
In FY 2025, the company raised strong financing support. It issued
equity shares worth 5,193.34 million
and preference shares of 14,561.00
million. The largest inflow came from long-term borrowings of 68,483.05 million and short-term
borrowings of 1,090.85 million. At
the same time, repayments of long-term borrowings stood at 37,901.77 million. Lease repayments (3,205.16 million) and interest payments (7,570.43 million) also reduced inflows. Despite these, net
financing cash inflow was 41,598.45
million in FY 2025, a strong reversal from an outflow of 24,131.87 million in FY 2024.
Net Cash Position
Combining all activities, the company achieved a net increase of 2,689.53 million in FY 2025, compared to a net decrease of 3,900.60 million in FY
2024. The year ended with a closing cash balance of 6,857.21 million, up from 4,082.19
million last year.
|
Particular |
31-03-2025 |
31-03-2024 |
|
Current Ratio (in times) |
6.78 |
13.64 |
|
Return on Equity Ratio (in %) |
2.74% |
(0.45)% |
|
Trade receivable Turnover Ratio (in times) |
0.16 |
0.25 |
|
Trade Payable Turnover Ratio (in times) |
2.56 |
4.89 |
|
Net Capital Turnover Ratio (in times) |
0.03 |
0.03 |
|
Net Profit Ratio (in %) |
2794.19% |
(334.07)% |
|
Return on Capital Employed Ratio (in %) |
1.46% |
(0.45)% |
|
Return on Investment (in %) |
12.86% |
5.95% |
Summary of the
financial ratio for the years 2025 and 2024
Current Ratio:
The current ratio fell from 13.64 in
2024 to 6.78 in 2025.
Even though it dropped, the ratio is still very high compared to the standard
benchmark of 1–2. This means the company has far more current assets than
current liabilities, showing a very strong liquidity position. However, too
high a ratio could also indicate underutilized assets.
Return on
Equity:
ROE improved sharply from a negative
-0.45% in 2024 to a positive
2.74% in 2025. This means the company is now generating profits
for its shareholders, after recording a loss the previous year. Although the
return is still modest, it reflects a clear turnaround in performance.
Trade
Receivable Turnover Ratio:
The receivable turnover declined from 0.25
times in 2024 to 0.16
times in 2025. This indicates that the company is collecting
payments from its customers more slowly, which may affect cash flow and working
capital efficiency.
Trade Payable
Turnover Ratio:
The ratio dropped from 4.89 times in
2024 to 2.56 times in
2025. This suggests the company is taking more time to pay its
suppliers compared to last year, which could be a deliberate move to manage
cash better, but may strain supplier relationships.
Net Capital
Turnover Ratio:
The net capital turnover ratio remained constant at 0.03 in both years, showing no
improvement in how efficiently the company is using its working capital to
generate sales. This indicates very low efficiency in utilizing capital for
revenue growth.
Net Profit
Ratio:
The net profit ratio shows a massive turnaround — from a negative -334.07% in 2024 to an
extraordinary 2,794.19% in 2025.
This dramatic shift suggests the company has moved from deep losses to
extremely high profitability, possibly due to one-time gains or significant
improvements in operations.
Return on
Capital Employed:
ROCE improved from -0.45% in 2024
to 1.46% in 2025.
This indicates that the company is now generating positive returns from its
overall capital, though the percentage remains modest, suggesting scope for
further efficiency.
Return on
Investment:
The ROI increased from 5.95% in 2024
to 12.86% in 2025.
This shows that the company’s investments are delivering much higher returns
compared to last year, reflecting improved financial performance and better
investment decisions.